Kathryn Haskins
Concepts (386)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 74 | 2023 | 3254 | 5.160 |
Why?
| Autoantigens | 32 | 2022 | 398 | 4.930 |
Why?
| CD4-Positive T-Lymphocytes | 32 | 2022 | 965 | 4.820 |
Why?
| Mice, Inbred NOD | 66 | 2022 | 560 | 3.490 |
Why?
| Chromogranin A | 8 | 2021 | 39 | 3.280 |
Why?
| Islets of Langerhans | 41 | 2022 | 729 | 3.020 |
Why?
| T-Lymphocytes | 48 | 2020 | 1756 | 2.700 |
Why?
| Receptors, Antigen, T-Cell | 28 | 2021 | 630 | 2.220 |
Why?
| Islet Amyloid Polypeptide | 5 | 2018 | 47 | 2.070 |
Why?
| Insulin | 15 | 2023 | 2082 | 2.060 |
Why?
| Epitopes, T-Lymphocyte | 9 | 2021 | 170 | 1.950 |
Why?
| Peptides | 14 | 2023 | 864 | 1.860 |
Why?
| Diabetes Mellitus, Experimental | 15 | 2020 | 161 | 1.750 |
Why?
| Autoimmunity | 14 | 2022 | 822 | 1.610 |
Why?
| Insulin-Secreting Cells | 8 | 2023 | 318 | 1.530 |
Why?
| Peptide Fragments | 10 | 2022 | 675 | 1.460 |
Why?
| C-Peptide | 4 | 2021 | 138 | 1.410 |
Why?
| Mice | 90 | 2023 | 15052 | 1.350 |
Why?
| T-Lymphocytes, Regulatory | 5 | 2021 | 342 | 1.270 |
Why?
| Clone Cells | 29 | 2018 | 248 | 1.220 |
Why?
| Animals | 98 | 2023 | 32102 | 1.070 |
Why?
| Epitopes | 12 | 2022 | 438 | 0.990 |
Why?
| CD40 Antigens | 4 | 2012 | 82 | 0.930 |
Why?
| Islets of Langerhans Transplantation | 6 | 2022 | 63 | 0.890 |
Why?
| T-Lymphocytes, Helper-Inducer | 3 | 2019 | 129 | 0.860 |
Why?
| Antigen-Presenting Cells | 7 | 2014 | 153 | 0.840 |
Why?
| Adoptive Transfer | 16 | 2015 | 199 | 0.840 |
Why?
| Lymphocyte Activation | 16 | 2020 | 1057 | 0.820 |
Why?
| Mice, SCID | 15 | 2018 | 321 | 0.750 |
Why?
| Th1 Cells | 5 | 2009 | 125 | 0.730 |
Why?
| Nanoparticles | 3 | 2022 | 316 | 0.700 |
Why?
| Graft Survival | 1 | 2022 | 480 | 0.670 |
Why?
| CD4 Antigens | 5 | 2013 | 124 | 0.650 |
Why?
| Cells, Cultured | 13 | 2020 | 3914 | 0.630 |
Why?
| Mice, Transgenic | 20 | 2021 | 1970 | 0.600 |
Why?
| Pancreas | 6 | 2013 | 280 | 0.590 |
Why?
| Mice, Inbred BALB C | 17 | 2016 | 1168 | 0.590 |
Why?
| Recombination, Genetic | 1 | 2018 | 177 | 0.580 |
Why?
| Recombinant Fusion Proteins | 3 | 2019 | 616 | 0.580 |
Why?
| Macrophages | 6 | 2009 | 1284 | 0.570 |
Why?
| Histocompatibility Antigens Class II | 6 | 2013 | 353 | 0.550 |
Why?
| Immunotherapy | 1 | 2019 | 479 | 0.500 |
Why?
| Autoimmune Diseases | 7 | 2018 | 395 | 0.490 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 9 | 2012 | 309 | 0.490 |
Why?
| CD40 Ligand | 2 | 2012 | 42 | 0.480 |
Why?
| Immune Tolerance | 5 | 2021 | 332 | 0.460 |
Why?
| Prediabetic State | 3 | 2013 | 225 | 0.450 |
Why?
| CD8-Positive T-Lymphocytes | 7 | 2021 | 693 | 0.440 |
Why?
| Th2 Cells | 2 | 2007 | 157 | 0.440 |
Why?
| Histocompatibility Antigens | 3 | 2011 | 100 | 0.440 |
Why?
| Mice, Knockout | 8 | 2021 | 2604 | 0.420 |
Why?
| Spleen | 11 | 2013 | 492 | 0.420 |
Why?
| Antigen Presentation | 2 | 2021 | 189 | 0.410 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2007 | 1137 | 0.400 |
Why?
| Oxidative Stress | 4 | 2007 | 1093 | 0.380 |
Why?
| Histocompatibility Antigens Class I | 1 | 2012 | 174 | 0.360 |
Why?
| Flow Cytometry | 8 | 2015 | 1083 | 0.360 |
Why?
| Antigens, CD | 3 | 2008 | 442 | 0.350 |
Why?
| Macrophage Activation | 2 | 2007 | 165 | 0.350 |
Why?
| Specific Pathogen-Free Organisms | 3 | 2018 | 60 | 0.340 |
Why?
| Diabetes Mellitus | 5 | 2014 | 906 | 0.330 |
Why?
| Cytokines | 9 | 2009 | 1853 | 0.320 |
Why?
| Mass Spectrometry | 4 | 2023 | 645 | 0.320 |
Why?
| Amino Acid Sequence | 7 | 2016 | 2000 | 0.320 |
Why?
| Interferon-gamma | 8 | 2020 | 726 | 0.310 |
Why?
| Receptors, CCR8 | 1 | 2007 | 2 | 0.300 |
Why?
| Chemokine CCL1 | 1 | 2007 | 2 | 0.300 |
Why?
| Major Histocompatibility Complex | 10 | 2006 | 219 | 0.290 |
Why?
| HLA-DQ Antigens | 3 | 2021 | 177 | 0.280 |
Why?
| Transforming Growth Factor beta | 1 | 2009 | 446 | 0.270 |
Why?
| Cell Line | 13 | 2013 | 2651 | 0.260 |
Why?
| Disease Models, Animal | 3 | 2019 | 3580 | 0.240 |
Why?
| T-Lymphocyte Subsets | 4 | 2003 | 383 | 0.240 |
Why?
| Thymus Gland | 5 | 2015 | 299 | 0.230 |
Why?
| Antibodies, Monoclonal | 12 | 2008 | 1265 | 0.230 |
Why?
| Humans | 35 | 2023 | 115587 | 0.230 |
Why?
| Tyrosine | 2 | 2005 | 219 | 0.230 |
Why?
| Transglutaminases | 2 | 2013 | 144 | 0.210 |
Why?
| Regeneration | 1 | 2004 | 162 | 0.200 |
Why?
| Female | 30 | 2022 | 59913 | 0.200 |
Why?
| Cell Movement | 4 | 2014 | 867 | 0.200 |
Why?
| CD11c Antigen | 2 | 2019 | 38 | 0.190 |
Why?
| Metalloporphyrins | 1 | 2002 | 106 | 0.190 |
Why?
| B-Lymphocytes | 3 | 2015 | 773 | 0.190 |
Why?
| Polymorphism, Genetic | 1 | 2004 | 621 | 0.190 |
Why?
| Crosses, Genetic | 3 | 2018 | 141 | 0.180 |
Why?
| Molecular Sequence Data | 4 | 2016 | 2790 | 0.180 |
Why?
| Antigens, Surface | 2 | 2000 | 151 | 0.180 |
Why?
| Transgenes | 1 | 2001 | 169 | 0.180 |
Why?
| Endogenous Retroviruses | 1 | 2020 | 19 | 0.180 |
Why?
| Gene Products, gag | 1 | 2020 | 36 | 0.180 |
Why?
| Antigens, Differentiation | 1 | 2000 | 79 | 0.170 |
Why?
| Cell Proliferation | 3 | 2019 | 2194 | 0.170 |
Why?
| HLA-DRB1 Chains | 1 | 2020 | 98 | 0.170 |
Why?
| Insulinoma | 2 | 2002 | 29 | 0.170 |
Why?
| Mice, Inbred Strains | 9 | 1998 | 399 | 0.170 |
Why?
| Recurrence | 1 | 2022 | 952 | 0.160 |
Why?
| Immunoconjugates | 1 | 2000 | 87 | 0.160 |
Why?
| Celiac Disease | 1 | 2021 | 266 | 0.160 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2012 | 2098 | 0.160 |
Why?
| Animals, Genetically Modified | 1 | 2019 | 215 | 0.160 |
Why?
| Cytoplasmic Granules | 3 | 2000 | 82 | 0.160 |
Why?
| Lymphoid Tissue | 1 | 2018 | 63 | 0.160 |
Why?
| Forkhead Transcription Factors | 1 | 2019 | 171 | 0.150 |
Why?
| Mice, Inbred C57BL | 6 | 2015 | 4773 | 0.150 |
Why?
| Exocytosis | 1 | 2018 | 89 | 0.150 |
Why?
| Immune System | 1 | 2019 | 173 | 0.150 |
Why?
| Chromatography, Gel | 2 | 2012 | 128 | 0.150 |
Why?
| Cell Differentiation | 4 | 2020 | 1700 | 0.150 |
Why?
| Leukocytes | 1 | 1998 | 281 | 0.140 |
Why?
| HLA-A2 Antigen | 1 | 2016 | 37 | 0.140 |
Why?
| Cytotoxicity, Immunologic | 3 | 2002 | 198 | 0.140 |
Why?
| Diabetic Angiopathies | 2 | 2011 | 244 | 0.130 |
Why?
| Cell Division | 3 | 2004 | 759 | 0.130 |
Why?
| Hybridomas | 11 | 2009 | 230 | 0.130 |
Why?
| Disease Progression | 3 | 2019 | 2418 | 0.130 |
Why?
| Microsatellite Repeats | 1 | 2015 | 137 | 0.130 |
Why?
| Antigens, Neoplasm | 2 | 1994 | 223 | 0.130 |
Why?
| Biocompatible Materials | 2 | 2012 | 378 | 0.130 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 795 | 0.130 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 2 | 2007 | 85 | 0.120 |
Why?
| Serine Endopeptidases | 1 | 2015 | 102 | 0.120 |
Why?
| Male | 19 | 2021 | 55949 | 0.120 |
Why?
| CTLA-4 Antigen | 2 | 2008 | 78 | 0.120 |
Why?
| Glutamate Decarboxylase | 3 | 2008 | 162 | 0.120 |
Why?
| Signal Transduction | 5 | 2012 | 4541 | 0.120 |
Why?
| Nitric Oxide | 3 | 2007 | 832 | 0.110 |
Why?
| Dendritic Cells | 2 | 2012 | 438 | 0.110 |
Why?
| Histocompatibility Testing | 1 | 2013 | 115 | 0.110 |
Why?
| Primary Cell Culture | 1 | 2013 | 149 | 0.110 |
Why?
| Microscopy, Fluorescence | 2 | 2012 | 402 | 0.110 |
Why?
| Proteomics | 2 | 2022 | 859 | 0.110 |
Why?
| Citrulline | 1 | 2013 | 39 | 0.100 |
Why?
| Amino Acid Motifs | 2 | 2010 | 198 | 0.100 |
Why?
| Fibrinogen | 1 | 2013 | 160 | 0.100 |
Why?
| Interleukin-2 | 4 | 2000 | 417 | 0.100 |
Why?
| Lymph Nodes | 2 | 2013 | 423 | 0.100 |
Why?
| Transduction, Genetic | 1 | 2012 | 114 | 0.100 |
Why?
| Arthritis, Experimental | 1 | 2013 | 133 | 0.090 |
Why?
| Transforming Growth Factor beta1 | 2 | 2012 | 156 | 0.090 |
Why?
| Lymphocyte Transfusion | 3 | 2005 | 19 | 0.090 |
Why?
| Complementarity Determining Regions | 2 | 2012 | 43 | 0.090 |
Why?
| Immunodominant Epitopes | 2 | 2009 | 26 | 0.090 |
Why?
| Carotid Artery Diseases | 1 | 2011 | 58 | 0.090 |
Why?
| RNA, Messenger | 4 | 2005 | 2574 | 0.090 |
Why?
| Autoantibodies | 3 | 2013 | 1360 | 0.090 |
Why?
| Endothelium, Vascular | 2 | 2007 | 845 | 0.090 |
Why?
| HLA-A Antigens | 1 | 2010 | 50 | 0.090 |
Why?
| Ovalbumin | 3 | 2021 | 166 | 0.090 |
Why?
| Up-Regulation | 2 | 2013 | 820 | 0.090 |
Why?
| Receptors, Interleukin-2 | 2 | 2000 | 65 | 0.080 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 2006 | 25 | 0.080 |
Why?
| Chromosome Mapping | 2 | 2004 | 489 | 0.080 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 52 | 0.080 |
Why?
| CD28 Antigens | 1 | 2008 | 47 | 0.080 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2008 | 58 | 0.080 |
Why?
| Gene Expression | 1 | 2013 | 1435 | 0.080 |
Why?
| Disease Susceptibility | 2 | 2004 | 316 | 0.080 |
Why?
| Polyethylene Glycols | 3 | 2012 | 576 | 0.080 |
Why?
| Biomarkers | 1 | 2018 | 3466 | 0.080 |
Why?
| Inducible T-Cell Co-Stimulator Protein | 1 | 2007 | 9 | 0.080 |
Why?
| Organ Specificity | 1 | 2008 | 273 | 0.080 |
Why?
| CD11b Antigen | 1 | 2007 | 58 | 0.070 |
Why?
| Macrophages, Peritoneal | 1 | 2007 | 93 | 0.070 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 139 | 0.070 |
Why?
| Chemotaxis | 1 | 2007 | 132 | 0.070 |
Why?
| Pancreatic Neoplasms | 1 | 1994 | 722 | 0.070 |
Why?
| Hydrogels | 3 | 2012 | 581 | 0.070 |
Why?
| Child | 5 | 2019 | 18488 | 0.070 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2004 | 21 | 0.070 |
Why?
| Mice, Mutant Strains | 3 | 1991 | 271 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 930 | 0.070 |
Why?
| Prostaglandins | 1 | 2005 | 78 | 0.060 |
Why?
| Isoenzymes | 1 | 2006 | 285 | 0.060 |
Why?
| Genes, T-Cell Receptor | 1 | 2005 | 6 | 0.060 |
Why?
| Receptors, Chemokine | 1 | 2005 | 43 | 0.060 |
Why?
| Receptors, Cytokine | 1 | 2005 | 33 | 0.060 |
Why?
| Species Specificity | 4 | 2006 | 552 | 0.060 |
Why?
| Immunoglobulin Allotypes | 1 | 1984 | 6 | 0.060 |
Why?
| Cell Adhesion Molecules | 1 | 2005 | 168 | 0.060 |
Why?
| Lymphocyte Depletion | 3 | 2000 | 116 | 0.060 |
Why?
| Arthritis, Rheumatoid | 1 | 2013 | 1002 | 0.060 |
Why?
| Rats | 5 | 2000 | 5034 | 0.060 |
Why?
| Mice, Congenic | 1 | 2004 | 21 | 0.060 |
Why?
| Aging | 4 | 2005 | 1631 | 0.060 |
Why?
| Molecular Mimicry | 1 | 2003 | 35 | 0.060 |
Why?
| Chemokines | 1 | 2005 | 214 | 0.060 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 312 | 0.060 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 746 | 0.060 |
Why?
| Aspartic Acid | 1 | 2023 | 79 | 0.060 |
Why?
| Genes, RAG-1 | 1 | 2003 | 11 | 0.060 |
Why?
| Extracellular Matrix | 1 | 2007 | 439 | 0.060 |
Why?
| Immunoglobulin G | 2 | 1997 | 781 | 0.050 |
Why?
| Cathepsin D | 1 | 2022 | 14 | 0.050 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 128 | 0.050 |
Why?
| Adolescent | 3 | 2019 | 17889 | 0.050 |
Why?
| DNA Primers | 1 | 2004 | 514 | 0.050 |
Why?
| Insulin, Regular, Human | 1 | 2022 | 33 | 0.050 |
Why?
| Vasodilation | 1 | 2005 | 412 | 0.050 |
Why?
| Solubility | 2 | 2000 | 226 | 0.050 |
Why?
| Glucose | 3 | 2007 | 904 | 0.050 |
Why?
| Antibody Specificity | 5 | 1996 | 176 | 0.050 |
Why?
| Respiratory Burst | 1 | 2002 | 28 | 0.050 |
Why?
| Molecular Weight | 5 | 2006 | 329 | 0.050 |
Why?
| RNA, Small Interfering | 1 | 2004 | 544 | 0.050 |
Why?
| Adult | 4 | 2019 | 30718 | 0.050 |
Why?
| Cytoprotection | 1 | 2021 | 53 | 0.050 |
Why?
| Superoxide Dismutase | 1 | 2003 | 332 | 0.050 |
Why?
| In Vitro Techniques | 1 | 2023 | 1044 | 0.050 |
Why?
| Leukemia L1210 | 1 | 2001 | 7 | 0.050 |
Why?
| K562 Cells | 1 | 2021 | 73 | 0.050 |
Why?
| Phosphotyrosine | 1 | 2001 | 33 | 0.050 |
Why?
| Interphase | 1 | 2001 | 32 | 0.050 |
Why?
| L-Selectin | 1 | 2001 | 25 | 0.050 |
Why?
| Perforin | 1 | 2001 | 19 | 0.050 |
Why?
| Gene Rearrangement | 1 | 2002 | 135 | 0.050 |
Why?
| Pore Forming Cytotoxic Proteins | 1 | 2001 | 15 | 0.050 |
Why?
| Antigens, Viral | 1 | 2021 | 177 | 0.050 |
Why?
| T-Cell Antigen Receptor Specificity | 2 | 2012 | 41 | 0.050 |
Why?
| Alleles | 1 | 2003 | 794 | 0.050 |
Why?
| Injections, Intravenous | 1 | 2001 | 204 | 0.050 |
Why?
| fas Receptor | 1 | 2001 | 93 | 0.050 |
Why?
| Integrins | 1 | 2001 | 79 | 0.050 |
Why?
| Chromatography, Ion Exchange | 1 | 2000 | 48 | 0.040 |
Why?
| Detergents | 1 | 2000 | 41 | 0.040 |
Why?
| Hemocyanins | 1 | 2000 | 57 | 0.040 |
Why?
| Abatacept | 1 | 2000 | 40 | 0.040 |
Why?
| Immunophenotyping | 1 | 2001 | 277 | 0.040 |
Why?
| Cross Reactions | 1 | 2020 | 117 | 0.040 |
Why?
| Antigens | 1 | 2021 | 323 | 0.040 |
Why?
| Cell Lineage | 1 | 2021 | 310 | 0.040 |
Why?
| Glycoproteins | 1 | 2021 | 309 | 0.040 |
Why?
| Mice, Inbred DBA | 3 | 2013 | 173 | 0.040 |
Why?
| Maternal-Fetal Exchange | 2 | 1997 | 151 | 0.040 |
Why?
| Promoter Regions, Genetic | 1 | 2004 | 1122 | 0.040 |
Why?
| Viral Proteins | 1 | 2021 | 286 | 0.040 |
Why?
| Clonal Anergy | 1 | 1999 | 53 | 0.040 |
Why?
| Cell-Derived Microparticles | 1 | 2020 | 58 | 0.040 |
Why?
| Gene Expression Regulation | 2 | 2012 | 2353 | 0.040 |
Why?
| Macromolecular Substances | 3 | 1991 | 200 | 0.040 |
Why?
| Pancreatitis | 1 | 2000 | 107 | 0.040 |
Why?
| Interleukin-13 | 1 | 1999 | 126 | 0.040 |
Why?
| Transfection | 1 | 2001 | 866 | 0.040 |
Why?
| Membrane Glycoproteins | 1 | 2001 | 431 | 0.040 |
Why?
| Lipopolysaccharides | 1 | 2002 | 826 | 0.040 |
Why?
| Intracellular Membranes | 1 | 1998 | 73 | 0.040 |
Why?
| Obesity | 1 | 1990 | 2517 | 0.040 |
Why?
| Muramidase | 1 | 1998 | 73 | 0.040 |
Why?
| NF-kappa B | 1 | 2002 | 639 | 0.040 |
Why?
| Immunity, Maternally-Acquired | 1 | 1997 | 22 | 0.040 |
Why?
| Antibodies | 1 | 2000 | 374 | 0.040 |
Why?
| Rats, Inbred Strains | 2 | 1990 | 376 | 0.040 |
Why?
| Materials Testing | 2 | 2012 | 356 | 0.040 |
Why?
| Multigene Family | 1 | 1997 | 193 | 0.040 |
Why?
| Animals, Newborn | 3 | 2005 | 780 | 0.040 |
Why?
| Tumor Cells, Cultured | 2 | 2000 | 850 | 0.040 |
Why?
| Glutathione | 1 | 1998 | 303 | 0.040 |
Why?
| Cloning, Molecular | 3 | 2003 | 523 | 0.030 |
Why?
| Phosphorylation | 1 | 2001 | 1571 | 0.030 |
Why?
| Cell Membrane | 1 | 2000 | 683 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2019 | 501 | 0.030 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 1316 | 0.030 |
Why?
| NADPH Oxidases | 2 | 2007 | 122 | 0.030 |
Why?
| Insulin Antibodies | 1 | 1996 | 102 | 0.030 |
Why?
| Heat-Shock Proteins | 1 | 1996 | 113 | 0.030 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 156 | 0.030 |
Why?
| Immunohistochemistry | 2 | 2000 | 1642 | 0.030 |
Why?
| Thymocytes | 1 | 2015 | 28 | 0.030 |
Why?
| Immunization | 2 | 1996 | 401 | 0.030 |
Why?
| Stromal Cells | 1 | 2015 | 97 | 0.030 |
Why?
| Mice, Inbred AKR | 4 | 1997 | 34 | 0.030 |
Why?
| Centrifugation, Density Gradient | 1 | 1994 | 41 | 0.030 |
Why?
| Membrane Proteins | 1 | 2000 | 1024 | 0.030 |
Why?
| Genetic Linkage | 1 | 1995 | 297 | 0.030 |
Why?
| Culture Techniques | 1 | 1994 | 80 | 0.030 |
Why?
| Cell Fractionation | 1 | 1994 | 53 | 0.030 |
Why?
| Binding Sites, Antibody | 2 | 1984 | 36 | 0.030 |
Why?
| Journal Impact Factor | 1 | 2014 | 27 | 0.030 |
Why?
| Antigen-Antibody Reactions | 2 | 1984 | 49 | 0.030 |
Why?
| Genetic Markers | 1 | 1995 | 325 | 0.030 |
Why?
| Gene Rearrangement, T-Lymphocyte | 1 | 1993 | 13 | 0.030 |
Why?
| Rats, Inbred BB | 1 | 1993 | 5 | 0.030 |
Why?
| Immunosuppressive Agents | 2 | 2012 | 666 | 0.030 |
Why?
| Cell Survival | 2 | 2007 | 1024 | 0.030 |
Why?
| Collagen Type II | 1 | 2013 | 48 | 0.030 |
Why?
| CD8 Antigens | 1 | 1992 | 69 | 0.030 |
Why?
| Young Adult | 2 | 2019 | 10470 | 0.030 |
Why?
| Immunity, Innate | 1 | 1998 | 731 | 0.030 |
Why?
| Trinitrobenzenes | 1 | 1992 | 13 | 0.030 |
Why?
| Adenoma, Islet Cell | 1 | 1992 | 10 | 0.030 |
Why?
| Haptens | 1 | 1992 | 21 | 0.030 |
Why?
| Hybrid Cells | 1 | 1992 | 49 | 0.030 |
Why?
| Publishing | 1 | 2014 | 127 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 1993 | 1000 | 0.030 |
Why?
| Immunoglobulin Idiotypes | 4 | 1983 | 19 | 0.020 |
Why?
| Kinetics | 1 | 1995 | 1569 | 0.020 |
Why?
| Receptors, Antigen, B-Cell | 1 | 1992 | 107 | 0.020 |
Why?
| Periodicals as Topic | 1 | 2014 | 183 | 0.020 |
Why?
| Coculture Techniques | 1 | 2012 | 202 | 0.020 |
Why?
| Mice, Nude | 1 | 1993 | 639 | 0.020 |
Why?
| Neointima | 1 | 2011 | 13 | 0.020 |
Why?
| Base Sequence | 2 | 1993 | 2114 | 0.020 |
Why?
| Germ-Line Mutation | 1 | 2012 | 131 | 0.020 |
Why?
| Mice, Inbred CBA | 1 | 1990 | 56 | 0.020 |
Why?
| Collagen | 1 | 2013 | 415 | 0.020 |
Why?
| CD4 Lymphocyte Count | 1 | 2011 | 257 | 0.020 |
Why?
| Sex Factors | 1 | 1995 | 1736 | 0.020 |
Why?
| Interleukin-10 | 1 | 2012 | 299 | 0.020 |
Why?
| Age Factors | 2 | 1995 | 2907 | 0.020 |
Why?
| Genes, MHC Class II | 1 | 1989 | 69 | 0.020 |
Why?
| Leukemia, Lymphoid | 2 | 2006 | 27 | 0.020 |
Why?
| Epitope Mapping | 1 | 2009 | 51 | 0.020 |
Why?
| Trypsin | 2 | 2006 | 67 | 0.020 |
Why?
| Pituitary Gland | 1 | 1989 | 152 | 0.020 |
Why?
| Lymphokines | 1 | 1988 | 115 | 0.020 |
Why?
| Conserved Sequence | 1 | 2009 | 219 | 0.020 |
Why?
| Cell Separation | 1 | 1988 | 293 | 0.020 |
Why?
| Tissue Distribution | 2 | 1985 | 324 | 0.020 |
Why?
| Stem Cell Transplantation | 1 | 2008 | 151 | 0.020 |
Why?
| Kidney Transplantation | 1 | 1992 | 558 | 0.020 |
Why?
| Salivary Glands | 1 | 2006 | 31 | 0.020 |
Why?
| Mucoproteins | 1 | 2005 | 10 | 0.020 |
Why?
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2005 | 3 | 0.020 |
Why?
| Acetophenones | 1 | 2005 | 14 | 0.020 |
Why?
| Onium Compounds | 1 | 2005 | 11 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2007 | 287 | 0.020 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 58 | 0.020 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2005 | 72 | 0.020 |
Why?
| Cell Adhesion | 1 | 2007 | 433 | 0.020 |
Why?
| Drug Compounding | 1 | 2005 | 89 | 0.020 |
Why?
| Acetylcholine | 1 | 2005 | 180 | 0.020 |
Why?
| History, 20th Century | 1 | 2006 | 273 | 0.020 |
Why?
| Precipitin Tests | 1 | 1984 | 90 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 1993 | 2125 | 0.010 |
Why?
| Isoelectric Point | 1 | 1984 | 22 | 0.010 |
Why?
| Disulfides | 1 | 1984 | 91 | 0.010 |
Why?
| Protein Binding | 1 | 2009 | 1917 | 0.010 |
Why?
| Genes, T-Cell Receptor alpha | 1 | 2003 | 11 | 0.010 |
Why?
| Genes, T-Cell Receptor beta | 1 | 2003 | 18 | 0.010 |
Why?
| Chemical Precipitation | 1 | 1983 | 38 | 0.010 |
Why?
| Aorta | 1 | 2005 | 353 | 0.010 |
Why?
| DNA, Complementary | 1 | 2003 | 258 | 0.010 |
Why?
| Inflammation | 2 | 2006 | 2499 | 0.010 |
Why?
| Receptors, Immunologic | 1 | 1983 | 203 | 0.010 |
Why?
| Oxidation-Reduction | 1 | 2005 | 924 | 0.010 |
Why?
| Homeostasis | 1 | 2005 | 577 | 0.010 |
Why?
| Haplotypes | 1 | 2003 | 457 | 0.010 |
Why?
| Time Factors | 1 | 2012 | 6165 | 0.010 |
Why?
| Blood Glucose | 3 | 1999 | 1824 | 0.010 |
Why?
| Growth Inhibitors | 1 | 2000 | 45 | 0.010 |
Why?
| Injections, Intraperitoneal | 1 | 2000 | 104 | 0.010 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2000 | 160 | 0.010 |
Why?
| Pancreatic Ducts | 1 | 2000 | 69 | 0.010 |
Why?
| Nitric Oxide Synthase | 1 | 2000 | 213 | 0.010 |
Why?
| Complement C5 | 1 | 1999 | 74 | 0.010 |
Why?
| Cell Transplantation | 1 | 1999 | 37 | 0.010 |
Why?
| Epithelium | 1 | 2000 | 297 | 0.010 |
Why?
| H-2 Antigens | 1 | 1999 | 111 | 0.010 |
Why?
| Rats, Wistar | 1 | 2000 | 368 | 0.010 |
Why?
| Models, Immunological | 1 | 1999 | 92 | 0.010 |
Why?
| Interleukin-4 | 1 | 1999 | 209 | 0.010 |
Why?
| Conalbumin | 1 | 1997 | 3 | 0.010 |
Why?
| Immune Sera | 1 | 1997 | 80 | 0.010 |
Why?
| Apoptosis | 1 | 2007 | 2377 | 0.010 |
Why?
| Superantigens | 1 | 1997 | 69 | 0.010 |
Why?
| Immunoglobulin E | 1 | 1999 | 328 | 0.010 |
Why?
| Enterotoxins | 1 | 1997 | 88 | 0.010 |
Why?
| Injections, Subcutaneous | 1 | 1997 | 137 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2000 | 757 | 0.010 |
Why?
| Genes, Immunoglobulin | 1 | 1996 | 26 | 0.010 |
Why?
| Spodoptera | 1 | 1996 | 37 | 0.010 |
Why?
| Baculoviridae | 1 | 1996 | 45 | 0.010 |
Why?
| Homeodomain Proteins | 1 | 1999 | 465 | 0.010 |
Why?
| Pregnancy | 2 | 1997 | 5548 | 0.010 |
Why?
| Antibody Formation | 1 | 1996 | 273 | 0.010 |
Why?
| Staphylococcus aureus | 1 | 1997 | 385 | 0.010 |
Why?
| Submandibular Gland | 1 | 1993 | 15 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1993 | 138 | 0.010 |
Why?
| Globins | 1 | 1989 | 22 | 0.010 |
Why?
| Antigens, Ly | 1 | 1984 | 45 | 0.000 |
Why?
| Isoelectric Focusing | 1 | 1983 | 34 | 0.000 |
Why?
| Chickens | 1 | 1983 | 183 | 0.000 |
Why?
| Immunologic Techniques | 1 | 1983 | 39 | 0.000 |
Why?
| Birds | 1 | 1983 | 77 | 0.000 |
Why?
| Molecular Conformation | 1 | 1983 | 139 | 0.000 |
Why?
| DNA | 1 | 1989 | 1356 | 0.000 |
Why?
|
|
Haskins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|